Hospital News
Return to Bladder Cancer Overview
More on Bladder Cancer
- Bexxar Effective as First-Line Treatment for Non-Hodgkin's Lymphoma Patients When Used With Chemotherapy
- Cancer Treatment Is First to Directly Target Tumor Blood Supply in Patients
- Combination of Abbreviated Chemotherapy with Radioactive Monoclonal Antibody Effective in Previously Untreated Non-Hodgkin's Lymphoma
- Coping With Chronic Cancer Pain
- Do Heart Disease and Cancer Have a Common Genetic Link?
- Health Effects of Secondhand Smoke Studied in First-of-Its-Kind Series of Clinical Studies
- Integrative Therapies Program for Children with Cancer at Morgan Stanley Children's Hospital of NewYork-Presbyterian Receives Gift Commitment from Origins Natural Resources
- Message to the Elderly: It's Never Too Late to Prevent Illness!
- New Book by Weill Cornell Psychiatrist Offers Insight and Hope for "Surviving Cancer Emotionally"
- NewYork-Presbyterian/Weill Cornell Creates World-Class Cancer Center
- NewYork-Presbyterian Hospital's Weill Cornell Medical Center Announces Preliminary Lung Cancer Data Involving Patients Treated With Arthritis Medication
- Scientists Identify Cells Necessary for Tumor Angiogenesis
- Study Looks at New Bladder Cancer Therapy for Patients Unresponsive to Standard Treatment
- The Seventh Issue of Cancer Prevention Has Arrived!
- Tumor Size Predicts Survival in Most Common Type of Lung Cancer
- Two Novel Biologics Studied for Multiple Myeloma
- Weill Cornell Researchers Announce New Gene Therapy Strategy To Promote Hair Growth
Health Library
Clinical Services
Return to Bladder Cancer Overview
More on Bladder Cancer
- Blood Cancer
- Brain Cancer
- Center for Holistic Urology
- Center for Lymphoma and Myeloma
- Colon Cancer
- Early Lung Cancer Action Program
- Edward S. Harkness Eye Institute
- Esophageal Cancer
- Eye Cancer
- Gastrointestinal Cancer
- Gynecological Cancer
- Head and Neck Cancer
- Kidney Cancer
- Leukemia and Myeloproliferative Disease Center
- Liver Cancer
- Lung Cancer
- Mesothelioma
- Oncology (Cancer)
- Pancreatic and Biliary Cancer
- Pediatric Cancer
- Prostate Cancer
- Rectal Cancer
- Robert M. Ellsworth Ophthalmic Oncology Center
- Soft Tissue and Bone Cancer
- Spirit of Care Program
- Stomach Cancer
- Testicular Cancer
- Urologic Cancer
Bladder Cancer
Therapeutic Excellence
Neobladder
New York-Presbyterian Hospital physicians performed the first continent urinary diversion operations in the northeastern United States and the first construction of a replacement neobladder (or new bladder) in New York State. The operations have revolutionized the care of patients who may require radial cystectomy, or bladder removal, by avoiding the need for an external appliance or bag following surgery. The neobladder is made from small intestine and attached to the urethra to help patients urinate in a more normal way. According to a recent study, complication rates following the surgery at NewYork-Presbyterian Hospital/Columbia University Medical Center were among the lowest ever reported.
Prevention
NewYork-Presbyterian Cancer Centers are leaders in preventive medicine for bladder cancer and are currently conducting extensive studies into the use of natural substances to inhibit the Cox-2 gene for prevention and treatment. In general, recommendations include abstaining from smoking, a significant risk factor for developing this disease, and using appropriate precautions to limit occupational exposure to certain dyes, rubber and leather, which have been shown to increase the risk of bladder cancer.
Hospital News
- Bexxar Effective as First-Line Treatment for Non-Hodgkin's Lymphoma Patients When Used With Chemotherapy
- Cancer Treatment Is First to Directly Target Tumor Blood Supply in Patients
- Combination of Abbreviated Chemotherapy with Radioactive Monoclonal Antibody Effective in Previously Untreated Non-Hodgkin's Lymphoma More
